Literature DB >> 24906641

Measures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals.

Sarah E Rutstein1, Deborah Kamwendo2, Lebah Lugali3, Isaac Thengolose2, Gerald Tegha2, Susan A Fiscus4, Julie A E Nelson4, Mina C Hosseinipour5, Abdoulaye Sarr6, Sundeep Gupta6, Frank Chimbwandira7, Reuben Mwenda7, Ronald Mataya8.   

Abstract

BACKGROUND: Viral suppression is a key indicator of antiretroviral therapy (ART) response among HIV-infected patients. Dried blood spots (DBS) are an appealing alternative to conventional plasma-based virologic testing, improving access to monitoring in resource-limited settings. However, validity of DBS obtained from fingerstick in field settings remains unknown.
OBJECTIVES: Investigate feasibility and accuracy of DBS vs plasma collected by healthcare workers in real-world settings of remote hospitals in Malawi. Compare venous DBS to fingerstick DBS for identifying treatment failure. STUDY
DESIGN: We recruited patients from ART clinics at two district hospitals in Malawi, collecting plasma, venous DBS (vDBS), and fingerstick DBS (fsDBS) cards for the first 149 patients, and vDBS and fsDBS only for the subsequent 398 patients. Specimens were tested using Abbott RealTime HIV-1 Assay (lower detection limit 40 copies/ml (plasma) and 550 copies/ml (DBS)).
RESULTS: 21/149 (14.1%) had detectable viremia (>1.6 log copies/ml), 13 of which were detectable for plasma, vDBS, and fsDBS. Linear regression demonstrated high correlation for plasma vs. DBS (vDBS: β=1.19, R(2)=0.93 (p<0.0001); fsDBS β=1.20, R(2)=0.90 (p<0.0001)) and vDBS vs. fsDBS (β=0.88, R(2)=0.73, (p<0.0001)). Mean difference between plasma and vDBS was 1.1 log copies/ml [SD: 0.27] and plasma and fsDBS 1.1 log copies/ml [SD: 0.31]. At 5000 copies/ml, sensitivity was 100%, and specificity was 98.6% and 97.8% for vDBS and fsDBS, respectively, compared to plasma.
CONCLUSIONS: DBS from venipuncture and fingerstick perform well at the failure threshold of 5000 copies/ml. Fingerstick specimen source may improve access to virologic treatment monitoring in resource-limited settings given task-shifting in high-volume, low-resource facilities.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24906641      PMCID: PMC4073118          DOI: 10.1016/j.jcv.2014.05.005

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  44 in total

1.  Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?

Authors:  Shashwatee Bagchi; Mirjam C Kempf; Andrew O Westfall; Anastasiya Maherya; James Willig; Michael S Saag
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

2.  Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.

Authors:  Rami Kantor; Lameck Diero; Allison Delong; Lydia Kamle; Sarah Muyonga; Fidelis Mambo; Eunice Walumbe; Wilfred Emonyi; Philip Chan; E Jane Carter; Joseph Hogan; Nathan Buziba
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

3.  Comparison of Ahlstrom grade 226, Munktell TFN, and Whatman 903 filter papers for dried blood spot specimen collection and subsequent HIV-1 load and drug resistance genotyping analysis.

Authors:  Erin Rottinghaus; Ebi Bile; Mosetsanagape Modukanele; Maruping Maruping; Madisa Mine; John Nkengasong; Chunfu Yang
Journal:  J Clin Microbiol       Date:  2012-10-17       Impact factor: 5.948

4.  Prospective evaluation of diagnostic accuracy of dried blood spots from finger prick samples for determination of HIV-1 load with the NucliSENS Easy-Q HIV-1 version 2.0 assay in Malawi.

Authors:  Emmanuel Fajardo; Carol A Metcalf; Pascale Chaillet; Lucia Aleixo; Pieter Pannus; Isabella Panunzi; Laura Triviño; Tom Ellman; Andrew Likaka; Reuben Mwenda
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

Review 5.  Dried blood spots in HIV monitoring: applications in resource-limited settings.

Authors:  Asgeir Johannessen
Journal:  Bioanalysis       Date:  2010-11       Impact factor: 2.681

6.  Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assay.

Authors:  Miguel Arredondo; Carolina Garrido; Neil Parkin; Natalia Zahonero; Silvia Bertagnolio; Vincent Soriano; Carmen de Mendoza
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

7.  Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon.

Authors:  André Dieudonné Mbida; Samuel Sosso; Pierre Flori; Henia Saoudin; Philip Lawrence; Marcel Monny-Lobé; Yves Oyono; Edward Ndzi; Giulia Cappelli; Frédéric Lucht; Bruno Pozzetto; Odile Ouwe Missi Oukem-Boyer; Thomas Bourlet
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

8.  Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy.

Authors:  Olivia Keiser; Patrick MacPhail; Andrew Boulle; Robin Wood; Mauro Schechter; François Dabis; Eduardo Sprinz; Matthias Egger
Journal:  Trop Med Int Health       Date:  2009-07-14       Impact factor: 2.622

9.  Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.

Authors:  Andrew N Phillips; Deenan Pillay; Alec H Miners; Diane E Bennett; Charles F Gilks; Jens D Lundgren
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

10.  Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

Authors:  P Mugyenyi; A S Walker; J Hakim; P Munderi; D M Gibb; C Kityo; A Reid; H Grosskurth; J H Darbyshire; F Ssali; D Bray; E Katabira; A G Babiker; C F Gilks; H Grosskurth; P Munderi; G Kabuye; D Nsibambi; R Kasirye; E Zalwango; M Nakazibwe; B Kikaire; G Nassuna; R Massa; K Fadhiru; M Namyalo; A Zalwango; L Generous; P Khauka; N Rutikarayo; W Nakahima; A Mugisha; J Todd; J Levin; S Muyingo; A Ruberantwari; P Kaleebu; D Yirrell; N Ndembi; F Lyagoba; P Hughes; M Aber; A Medina Lara; S Foster; J Amurwon; B Nyanzi Wakholi; J Whitworth; K Wangati; B Amuron; D Kajungu; J Nakiyingi; W Omony; K Fadhiru; D Nsibambi; P Khauka; P Mugyenyi; C Kityo; F Ssali; D Tumukunde; T Otim; J Kabanda; H Musana; J Akao; H Kyomugisha; A Byamukama; J Sabiiti; J Komugyena; P Wavamunno; S Mukiibi; A Drasiku; R Byaruhanga; O Labeja; P Katundu; S Tugume; P Awio; A Namazzi; G T Bakeinyaga; H Katabira; D Abaine; J Tukamushaba; W Anywar; W Ojiambo; E Angweng; S Murungi; W Haguma; S Atwiine; J Kigozi; L Namale; A Mukose; G Mulindwa; D Atwiine; A Muhwezi; E Nimwesiga; G Barungi; J Takubwa; S Murungi; D Mwebesa; G Kagina; M Mulindwa; F Ahimbisibwe; P Mwesigwa; S Akuma; C Zawedde; D Nyiraguhirwa; C Tumusiime; L Bagaya; W Namara; J Kigozi; J Karungi; R Kankunda; R Enzama; A Latif; J Hakim; V Robertson; A Reid; E Chidziva; R Bulaya-Tembo; G Musoro; F Taziwa; C Chimbetete; L Chakonza; A Mawora; C Muvirimi; G Tinago; P Svovanapasis; M Simango; O Chirema; J Machingura; S Mutsai; M Phiri; T Bafana; M Chirara; L Muchabaiwa; M Muzambi; J Mutowo; T Chivhunga; E Chigwedere; M Pascoe; C Warambwa; E Zengeza; F Mapinge; S Makota; A Jamu; N Ngorima; H Chirairo; S Chitsungo; J Chimanzi; C Maweni; R Warara; M Matongo; S Mudzingwa; M Jangano; K Moyo; L Vere; N Mdege; I Machingura; E Katabira; A Ronald; A Kambungu; F Lutwama; I Mambule; A Nanfuka; J Walusimbi; E Nabankema; R Nalumenya; T Namuli; R Kulume; I Namata; L Nyachwo; A Florence; A Kusiima; E Lubwama; R Nairuba; F Oketta; E Buluma; R Waita; H Ojiambo; F Sadik; J Wanyama; P Nabongo; J Oyugi; F Sematala; A Muganzi; C Twijukye; H Byakwaga; R Ochai; D Muhweezi; A Coutinho; B Etukoit; C Gilks; K Boocock; C Puddephatt; C Grundy; J Bohannon; D Winogron; D M Gibb; A Burke; D Bray; A Babiker; A S Walker; H Wilkes; M Rauchenberger; S Sheehan; C Spencer-Drake; K Taylor; M Spyer; A Ferrier; B Naidoo; D Dunn; R Goodall; J H Darbyshire; L Peto; R Nanfuka; C Mufuka-Kapuya; P Kaleebu; D Pillay; V Robertson; D Yirrell; S Tugume; M Chirara; P Katundu; N Ndembi; F Lyagoba; D Dunn; R Goodall; A McCormick; A Medina Lara; S Foster; J Amurwon; B Nyanzi Wakholi; J Kigozi; L Muchabaiwa; M Muzambi; I Weller; A Babiker; S Bahendeka; M Bassett; A Chogo Wapakhabulo; J H Darbyshire; B Gazzard; C Gilks; H Grosskurth; J Hakim; A Latif; C Mapuchere; O Mugurungi; P Mugyenyi; C Burke; S Jones; C Newland; G Pearce; S Rahim; J Rooney; M Smith; W Snowden; J-M Steens; A Breckenridge; A McLaren; C Hill; J Matenga; A Pozniak; D Serwadda; T Peto; A Palfreeman; M Borok; E Katabira
Journal:  Lancet       Date:  2009-12-08       Impact factor: 79.321

View more
  20 in total

1.  On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.

Authors:  S E Rutstein; C E Golin; S B Wheeler; D Kamwendo; M C Hosseinipour; M Weinberger; W C Miller; A K Biddle; A Soko; M Mkandawire; R Mwenda; A Sarr; S Gupta; R Mataya
Journal:  AIDS Care       Date:  2015-08-17

2.  Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model.

Authors:  Phillip Salvatore; Karl Johnson; Lara Vojnov; Meg Doherty; David Dowdy
Journal:  J Acquir Immune Defic Syndr       Date:  2019-11-01       Impact factor: 3.731

3.  Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.

Authors:  Mina Hosseinipour; Julie A E Nelson; Clement Trapence; Sarah E Rutstein; Florence Kasende; Virginia Kayoyo; Blessings Kaunda-Khangamwa; Kara Compliment; Christopher Stanley; Fabian Cataldo; Monique van Lettow; Nora E Rosenberg; Hannock Tweya; Salem Gugsa; Veena Sampathkumar; Erik Schouten; Michael Eliya; Frank Chimbwandira; Levison Chiwaula; Atupele Kapito-Tembo; Sam Phiri
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

Review 4.  Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples.

Authors:  Ming-Yih Wu; Hong-Nerng Ho
Journal:  World J Virol       Date:  2015-05-12

5.  The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi.

Authors:  Kathryn E Lancaster; Thandie Lungu; Pearson Mmodzi; Mina C Hosseinipour; Katy Chadwick; Kimberly A Powers; Brian W Pence; Vivian F Go; Irving F Hoffman; William C Miller
Journal:  AIDS Care       Date:  2016-07-21

6.  Sustainable HIV treatment in Africa through viral-load-informed differentiated care.

Authors:  Andrew Phillips; Amir Shroufi; Lara Vojnov; Jennifer Cohn; Teri Roberts; Tom Ellman; Kimberly Bonner; Christine Rousseau; Geoff Garnett; Valentina Cambiano; Fumiyo Nakagawa; Deborah Ford; Loveleen Bansi-Matharu; Alec Miners; Jens D Lundgren; Jeffrey W Eaton; Rosalind Parkes-Ratanshi; Zachary Katz; David Maman; Nathan Ford; Marco Vitoria; Meg Doherty; David Dowdy; Brooke Nichols; Maurine Murtagh; Meghan Wareham; Kara M Palamountain; Christine Chakanyuka Musanhu; Wendy Stevens; David Katzenstein; Andrea Ciaranello; Ruanne Barnabas; R Scott Braithwaite; Eran Bendavid; Kusum J Nathoo; David van de Vijver; David P Wilson; Charles Holmes; Anna Bershteyn; Simon Walker; Elliot Raizes; Ilesh Jani; Lisa J Nelson; Rosanna Peeling; Fern Terris-Prestholt; Joseph Murungu; Tsitsi Mutasa-Apollo; Timothy B Hallett; Paul Revill
Journal:  Nature       Date:  2015-12-03       Impact factor: 49.962

7.  Performance evaluation of the Aptima HIV-1 RNA Quant assay on the Panther system using the standard and dilution protocols.

Authors:  Rebecca Rossetti; Tara Smith; Wei Luo; Jennifer Taussig; Mariah Valentine-Graves; Patrick Sullivan; Jessica M Ingersoll; Colleen S Kraft; Steve Ethridge; Laura Wesolowski; Kevin P Delaney; S Michele Owen; Jeffrey A Johnson; Silvina Masciotra
Journal:  J Clin Virol       Date:  2020-06-01       Impact factor: 3.168

8.  Field evaluation of HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Nigeria by dried blood spot testing with RealTime HIV-1 on m2000.

Authors:  Monday Tola; Ramadhani O Habib; Adebajo Sylvia; Trevor A Crowell; Nowak G Rebecca; Manhattan E Charurat; Patrick Dakum; Nicaise Ndembi
Journal:  J Clin Virol       Date:  2020-11-25       Impact factor: 14.481

9.  Finger Prick Dried Blood Spots for HIV Viral Load Measurement in Field Conditions in Zimbabwe.

Authors:  Sue Napierala Mavedzenge; Calum Davey; Tarisai Chirenje; Phyllis Mushati; Sibongile Mtetwa; Jeffrey Dirawo; Boniface Mudenge; Andrew Phillips; Frances M Cowan
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

10.  Dried blood spots for viral load monitoring in Malawi: feasible and effective.

Authors:  Sarah E Rutstein; Mina C Hosseinipour; Deborah Kamwendo; Alice Soko; Memory Mkandawire; Andrea K Biddle; William C Miller; Morris Weinberger; Stephanie B Wheeler; Abdoulaye Sarr; Sundeep Gupta; Frank Chimbwandira; Reuben Mwenda; Steve Kamiza; Irving Hoffman; Ronald Mataya
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.